Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2007 2
2008 4
2009 8
2010 3
2011 6
2012 6
2013 9
2014 7
2015 5
2016 4
2017 5
2018 6
2019 4
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
Assessing liver stiffness with conventional cut-off values overestimates liver fibrosis staging in patients who received the Fontan procedure.
Cho Y, Kabata D, Ehara E, Yamamoto A, Mizuochi T, Mushiake S, Kusano H, Kuwae Y, Suzuki T, Uchida-Kobayashi S, Morikawa H, Amano-Teranishi Y, Kioka K, Jogo A, Isoura Y, Hamazaki T, Murakami Y, Tokuhara D. Cho Y, et al. Among authors: morikawa h. Hepatol Res. 2021 May;51(5):593-602. doi: 10.1111/hepr.13627. Epub 2021 Mar 6. Hepatol Res. 2021. PMID: 33677839
Serum Mac-2-binding protein glycosylation isomer predicts esophagogastric varices in cirrhotic patients with chronic hepatitis C virus infection treated with IFN-free direct-acting antiviral agent: M2BPGi levels predict varices in SVR patients.
Kikukawa K, Uchida-Kobayashi S, Tamori A, Yoshida K, Kotani K, Motoyama H, Kozuka R, Hagihara A, Fujii H, Morikawa H, Enomoto M, Murakami Y, Kawada N. Kikukawa K, et al. Among authors: morikawa h. Ann Hepatol. 2020 Jul-Aug;19(4):367-372. doi: 10.1016/j.aohep.2020.04.002. Epub 2020 May 11. Ann Hepatol. 2020. PMID: 32444247 Free article.
Interstitial pneumonia suspected during regorafenib administration and exacerbated by subsequent therapy with lenvatinib for unresectable hepatocellular carcinoma.
Kotani K, Enomoto M, Okada M, Yoshida K, Motoyama H, Fujii H, Hagihara A, Uchida-Kobayashi S, Morikawa H, Murakami Y, Tamori A, Kawada N. Kotani K, et al. Among authors: morikawa h. Clin J Gastroenterol. 2019 Aug;12(4):355-360. doi: 10.1007/s12328-019-00983-x. Epub 2019 Apr 24. Clin J Gastroenterol. 2019. PMID: 31020569
Short-term histological evaluations after achieving a sustained virologic response to direct-acting antiviral treatment for chronic hepatitis C.
Enomoto M, Ikura Y, Tamori A, Kozuka R, Motoyama H, Kawamura E, Hagihara A, Fujii H, Uchida-Kobayashi S, Morikawa H, Murakami Y, Kawada N. Enomoto M, et al. Among authors: morikawa h. United European Gastroenterol J. 2018 Nov;6(9):1391-1400. doi: 10.1177/2050640618791053. Epub 2018 Jul 19. United European Gastroenterol J. 2018. PMID: 30386612 Free PMC article.
Association between Functional Dyspepsia and Gastric Depressive Erosions in Japanese Subjects.
Tanaka F, Tominaga K, Fujikawa Y, Morisaki T, Otani K, Hosomi S, Nagami Y, Kamata N, Taira K, Nakano A, Kimura T, Yamagami H, Tanigawa T, Morikawa H, Fukumoto S, Watanabe T, Kawada N, Hirata K, Fujiwara Y. Tanaka F, et al. Among authors: morikawa h. Intern Med. 2019 Feb 1;58(3):321-328. doi: 10.2169/internalmedicine.1325-18. Epub 2018 Sep 12. Intern Med. 2019. PMID: 30210122 Free PMC article.
Changes in plasma interleukin-8 and tumor necrosis factor-α levels during the early treatment period as a predictor of the response to sorafenib in patients with unresectable hepatocellular carcinoma.
Iida-Ueno A, Enomoto M, Uchida-Kobayashi S, Hagihara A, Teranishi Y, Fujii H, Morikawa H, Murakami Y, Tamori A, Thuy LTT, Kawada N. Iida-Ueno A, et al. Among authors: morikawa h. Cancer Chemother Pharmacol. 2018 Nov;82(5):857-864. doi: 10.1007/s00280-018-3681-x. Epub 2018 Sep 3. Cancer Chemother Pharmacol. 2018. PMID: 30178114
Correction: Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication.
Motoyama H, Tamori A, Kubo S, Uchida-Kobayashi S, Takemura S, Tanaka S, Ohfuji S, Teranishi Y, Kozuka R, Kawamura E, Hagihara A, Morikawa H, Enomoto M, Murakami Y, Kawada N. Motoyama H, et al. Among authors: morikawa h. PLoS One. 2018 Jul 24;13(7):e0201423. doi: 10.1371/journal.pone.0201423. eCollection 2018. PLoS One. 2018. PMID: 30040864 Free PMC article.
Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication.
Motoyama H, Tamori A, Kubo S, Uchida-Kobayashi S, Takemura S, Tanaka S, Ohfuji S, Teranishi Y, Kozuka R, Kawamura E, Hagihara A, Morikawa H, Enomoto M, Murakami Y, Kawada N. Motoyama H, et al. Among authors: morikawa h. PLoS One. 2018 Mar 13;13(3):e0194163. doi: 10.1371/journal.pone.0194163. eCollection 2018. PLoS One. 2018. PMID: 29534101 Free PMC article.
63 results